SHC: financial statements from SEC — TradeAlmanac

SHC

Sotera Health Company: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31 Mar 2026	30 Sept 2025	30 Jun 2025	31 Mar 2025	30 Sept 2024	30 Jun 2024
Revenue	280M	311M	294M	255M	285M	277M
Cost of revenue	133M	134M	128M	119M	127M	124M
Gross profit	147M	178M	167M	135M	158M	153M
Selling, general and administrative	68M	63M	69M	63M	62M	61M
Operating expenses	—	—	—	—	78M	76M
Operating income	—	—	—	—	81M	77M
Pre-tax income	43M	73M	19M	−15M	43M	15M
Income tax	16M	25M	11M	−2M	26M	6M
Net income	27M	48M	8M	−13M	17M	9M
Earnings per share	0.09	0.17	0.03	−0.05	0.06	0.03
Earnings per share, diluted	0.09	0.17	0.03	−0.05	0.06	0.03
Weighted average shares	285M	284M	284M	284M	283M	283M
Weighted average shares, diluted	288M	287M	286M	284M	286M	285M

Balance sheet

Metric	31 Mar 2026	31 Dec 2025	30 Sept 2025	30 Jun 2025	31 Mar 2025	31 Dec 2024	30 Sept 2024	30 Jun 2024
Cash and equivalents	314M	345M	299M	332M	304M	277M	308M	248M
Receivables	137M	139M	142M

Cash flow

Metric	31 Mar 2026	31 Mar 2025
Operating cash flow	29M	56M
Depreciation and amortisation	25M	22M
Share-based compensation	14M	7M
Capital expenditure	46M	20M
Investing cash flow	−45M	−20M
Financing cash flow	−13M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator